SCHEMBL9496883

SCHEMBL9496883

CN(C(=O)CC(N)=O)C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
PKM P14618 1/20 0.44
NPBWR1 P48145 1/20 0.44
PABPC1 P11940 1/20 0.44
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
FAAH O00519 1/20 0.41
PHGDH O43175 1/20 0.41
MGLL Q99685 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 2/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
BACE1 P56817 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129642 0.88 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1PKMNPBWR1
SCHEMBL15224297 0.83 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1PKMNPBWR1
SCHEMBL14902207 0.82 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1PKMNPBWR1
SCHEMBL28230970 0.81 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1NPSR1KDM4E
SCHEMBL15016380 0.81 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1PKMNPBWR1
SCHEMBL19668292 0.80 KMT2A (0.45) ALDH1A1KMT2APKMKDM4EL3MBTL1
SCHEMBL7080112 0.80 KMT2A (0.41) ALDH1A1KMT2AMEN1NPSR1PHGDH
SCHEMBL4145907 0.80 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1PKMNPBWR1
SCHEMBL10723835 0.79 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1PKMNPBWR1
Magnesium SCHEMBL29521337 0.78 KMT2A (0.40) ALDH1A1KMT2AMEN1PKMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
EP-0333080-B1 BETA-CARBONYL-CARBOXYAMIDES OF 1,3-THIAZOLIDINES BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1993-10-13 EP disclosed
US-5206254-A Antitussive agents BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1993-04-27 US disclosed
EP-0407403-A1 BETA-CARBONYL-CARBOXYAMIDES OF 1,3-THIAZOLIDINES BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) 1991-01-16 EP disclosed
WO-1989008648-A1 beta-CARBONYL-CARBOXYAMIDES OF 1,3-THIAZOLIDINES BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) 1989-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 ALDH1A1 144/4885KMT2A 3868/4885MEN1 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.